Actively Recruiting
Intermittent Fasting and Mediterranean Diet in Patient With Multiple Sclerosis
Led by Nigde Omer Halisdemir University · Updated on 2024-08-09
34
Participants Needed
1
Research Sites
134 weeks
Total Duration
On this page
Sponsors
N
Nigde Omer Halisdemir University
Lead Sponsor
A
Acibadem University
Collaborating Sponsor
AI-Summary
What this Trial Is About
When the literature was reviewed, there is no study in which the effects of intermittent fasting and Mediterranean diet on quality of life, sleep, circadian rhythm and appetite hormones leptin and ghrelin levels in MS patients were evaluated and the two diet types were comparatively examined in terms of all these parameters.
CONDITIONS
Official Title
Intermittent Fasting and Mediterranean Diet in Patient With Multiple Sclerosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female between 18 and 65 years old diagnosed with MS by a physician
- Not currently in an attack period
- Not in menopause
- No autoimmune disease other than MS that affects the study
- Not following Mediterranean diet or intermittent fasting in the past 3 months
- No diagnosis of eating behavior disorder
- No communication problems
- Signed informed consent form
- Brain MRI within the last 3 months
- Not pregnant or lactating
- No physical disability
- No history of cancer
- Body Mass Index between 18.5 and 29.9 kg/m2
- No loss of 5% or more body weight in the last month
You will not qualify if you...
- Diagnosis of autoimmune disease other than MS that affects the study
- Currently in an attack period
- Under 18 or over 65 years old
- In menopause
- Following Mediterranean diet or intermittent fasting in the last 3 months
- Receiving diet therapy affecting the autoimmune system in the last 3 months
- Diagnosed with eating behavior disorder
- Communication problems
- Did not sign informed consent
- Unable to adapt to the study or behaviors adversely affecting participation
- Used nutritional interventions in the last 3 months
- Taking supplements like selenium, zinc, iron, vitamin D, or B12 affecting the study
- History or current cancer treatment
- Other neurological diseases such as Parkinson's, epilepsy, Alzheimer's
- Diagnosed with disease lasting more than 4 months in the last 12 months
- Following specialized dietary patterns (high protein, ketogenic, low energy <1000 kcal/day)
- Body Mass Index less than 18.5 or greater than 30 kg/m2
- Lost 5% or more body weight in the last month
- Having a physical disability
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nigde Omer Halisdemir University
Niğde, Bor, Turkey (Türkiye), 51200
Actively Recruiting
Research Team
E
Elif Gökçe İnbaşı, MSc.
CONTACT
N
Nihan Çakır Biçer, PhD.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here